Association Between Research Sponsorship and Study Outcome in Plastic Surgery Literature

作者: Arash Momeni , Axel Becker , Holger Bannasch , Gerd Antes , Anette Blümle

DOI: 10.1097/SAP.0B013E3181951917

关键词:

摘要: Financial and other competing interests have recently received increasing attention. In particular clinical research in plastic surgery attracts for-profit organizations, thus, explaining the number of financial sponsorships. However, articles often lack sufficient description study design as well disclosure source funding. Furthermore, debate exists whether industry funding influences findings is leading to pro-industry results. A hand search was conducted identifying all randomized controlled (RCT) trials (CCT) 4 journals (Plastic Reconstructive Surgery, British Journal Plastic Annals Aesthetic Surgery) between 1990 2005. Subsequently, influence support on outcome analyzed. total 10,476 original were analyzed, resulting identification 346 which meet Cochrane criteria for RCTs CCTs. One hundred eighty-three 163 studies found be CCTs, respectively. Hereof, only 70 (20.2%) reported grant support. Of these, 42 (60%) supported by industry. Depending topic addressed marked differences detected regarding Studies with a focus reconstructive public institutions almost equal shares (18 vs. 15 trials), whereas aesthetic surgical topics predominantly funded (13 6 trials). Industry-funded more statistically significant treatment arms (28 16 Authors' conclusions positively associated interests. trial rarely declared literature. Thus, quality reporting needs improved able investigate these relationships greater detail draw representative conclusions.

参考文章(35)
Richard Smith, Beyond conflict of interest: transparency is the key BMJ. ,vol. 317, pp. 291- 292 ,(1998) , 10.1136/BMJ.317.7154.291
Holger Schünemann, Victor M. Montori, Emil H. Schemitsch, Dianne Jackowski, Jason W. Busse, Sheila Sprague, Mohit Bhandari, Derek Mears, Dianne Heels-Ansdell, P.J. Devereaux, Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials Canadian Medical Association Journal. ,vol. 170, pp. 477- 480 ,(2004)
Sponsorship, authorship, and accountability. The New England Journal of Medicine. ,vol. 345, pp. 825- 827 ,(2001) , 10.1056/NEJMED010093
David Blumenthal, Withholding Research Results in Academic Life Science JAMA. ,vol. 277, pp. 1224- 1228 ,(1997) , 10.1001/JAMA.1997.03540390054035
Helle Krogh Johansen, Peter C Gøtzsche, Problems in the Design and Reporting of Trials of Antifungal Agents Encountered During Meta-analysis JAMA. ,vol. 282, pp. 1752- 1759 ,(1999) , 10.1001/JAMA.282.18.1752
Hamilton Moses III, Joseph B. Martin, Academic Relationships With Industry JAMA. ,vol. 285, pp. 933- 935 ,(2001) , 10.1001/JAMA.285.7.933
Justin E. Bekelman, Yan Li, Cary P. Gross, Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review JAMA. ,vol. 289, pp. 454- 465 ,(2003) , 10.1001/JAMA.289.4.454
Benjamin Djulbegovic, Mensura Lacevic, Alan Cantor, Karen K Fields, Charles L Bennett, Jared R Adams, Nicole M Kuderer, Gary H Lyman, The uncertainty principle and industry-sponsored research The Lancet. ,vol. 356, pp. 635- 638 ,(2000) , 10.1016/S0140-6736(00)02605-2
Arash Momeni, Axel Becker, Gerd Antes, Markus Diener, Anette Bluemle, G Stark Bjoern, Evidence-based plastic surgery: controlled trials in three plastic surgical journals (1990-2005). Annals of Plastic Surgery. ,vol. 61, pp. 221- 225 ,(2008) , 10.1097/SAP.0B013E31815F39DC